Immunogenicity Conference 2016

SMi is proud to announce the return of their 3rd annual Immunogenicity event to London in 2016! Immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due to the emergence or re-emergence of infectious pathogens with the potential for worldwide spread. With the global vaccine market expected to reach $84.44 billion by 2022, now is the time engage with industry experts to addresses the real challenges with immunogenicity including assay assessment, the role of aggregation, the introduction of nanobodies and many more! Register by 31st March to save £400! Register by 29th April to save £200! Booking: http://atnd.it/48218-0